Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Cortech announces further delays in development of Bradycor

Nov. 8, 1996

Taisho discloses agent for cerebrovascular disorders

Nov. 8, 1996

Mitsubishi reports cathepsin B/calpain inhibitors

Nov. 8, 1996

Trophix-Children's Hospital neurodegeneration research collaboration

Nov. 8, 1996

Histamine H3 receptor ligands described by INSERM/Bioprojet

Nov. 8, 1996

Mylan generic drug approved by FDA

Nov. 8, 1996

ImmuLogic's MS therapeutic nearing the clinic

Nov. 8, 1996

FDA approval for Faulding generic anticonvulsant

Nov. 8, 1996

Nicotine analogues proposed for treatment of depression

Nov. 8, 1996

Risperidone + clozapine effective in chronic schizophrenia

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...